Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 14,131

Document Document Title
WO/2019/048590A1
The present invention relates to a carbonic acid adduct (CAA) comprising carbonic acid, at least one amine, and optionally at least one salt, said adduct being producible by a method comprising the following steps: a) providing a solutio...  
WO/2019/026004A3
The present invention provides a process of synthesizing 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-( (2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3 yl)amino)ethylidene)amino)oxy)cyclopropanecarboxylic acid (referred to ...  
WO/2019/037591A1
The present invention relates to a melphalan hydrochloride crystal form, a preparation method therefor and an application thereof. The preparation method is convenient to operate, has a short reaction period, reduces environmental pollut...  
WO/2019/040177A1
There is disclosed a process for the purification of long chain amino acids by recrystallization in an aqueous solution of organic carboxylic acid in the absence or presence of solvent, comprising: (1) dissolving a long chain amino acid ...  
WO/2019/038764A1
The present invention relates to lyso-diacylglyceryltrimethylhomoserine (lyso- DGTS) or derivatives thereof for use in the treatment of atherosclerotic cardiovascular disease, and further provides particular such lyso-DGTS derivatives.  
WO/2019/036028A1
Compounds are provided having the following structure (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein G1, G1', G2, G2', G3, L1, L1', L2, L2', X, X', Y and Y' are as defined herein. Use of the compound...  
WO/2019/036008A1
Compounds are provided having the following structure: [Formula should be inserted here] or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R3, L1, L2, G1, G2 and G3 are as defined herein. Use of the compoun...  
WO/2019/036030A1
Compounds are provided having the following structure (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein X, Y, L1, L2, L3, G1, G2 and G3 are as defined herein. Use of the compounds as a component of lipi...  
WO/2019/036000A1
Compounds are provided having the following structure (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1a, R1b, R2a, R2b, R3a, R3b, R4a, R4b, R5, R6, R7, R8, L1, L2, G1, G2, G3, a, b, c and d are as d...  
WO/2019/034114A1
Provided is a composition containing L-carnitine-β-hydroxybutyrate wherein the L-carnitine and β-hydroxybutyrate compounds in the molecule exist in the form of an intramolecular salt, and the composition is used for losing weight and p...  
WO/2019/033216A1
There is provided a method for inhibiting growth of a microbial pathogen of a plant. The method includes applying to the plant a combination including a nitrogen-bearing macrocyclic compound which is a singlet oxygen photosensitizer sele...  
WO/2019/031472A1
[Problem] The purpose of the invention is to develop, as drug-candidate compounds, a group of novel compounds having the activity of inhibiting functions of Pin1. [Solution] The invention provides: a compound represented by formula (I) o...  
WO/2019/030158A1
The present invention relates to cocrystalsof2-[(1R,6R)-6-isopropenyl-3-methylcyclohex- 2-en-1-yl]-5-pentylbenzene-1,3-diol and a zwitterion coformer, processes for their preparation, and their use as a medicament and for the purificatio...  
WO/2019/023791A1
An aqueous formulation comprising levothyroxine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients and methods of using such formulation to treat a subject.  
WO/2019/027459A1
Nitric oxide levels in the blood stream are maintained while delivering, in sustained release, medication or therapeutic agent such as an nsaid (e.g. aspirin). This is accomplished by processing, at room temperature or in a low pressure ...  
WO/2019/026004A2
The present invention provides a process of synthesizing 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-( (2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3 yl)amino)ethylidene)amino)oxy)cyclopropanecarboxylic acid (referred to ...  
WO/2019/015794A1
The present invention relates to a chemical compound according to general formula (1).  
WO/2019/016354A1
The invention relates to a novel amino acid having a norbornene group and polypeptide comprising the novel amino acid compounds. The invention also relates to a method of producing polypeptides comprising a norbornene group and to the us...  
WO/2019/012545A1
Hybrid hydrogels, made of a three-dimensional network of fibrillar nanostructures, at least a portion of the fibrillar nanostructures being formed of at least two different types of aromatic moieties, at least one type of the aromatic mo...  
WO/2019/014207A1
The present invention relates to a composition comprising a lithium salt of an N-substituted glycine compound and a carrier, wherein the lithium salt of the N-substituted glycine compound is of Formula (I) in which R1, R2, and R3 each ar...  
WO/2019/007944A1
The present invention relates to a methylglycine-N,N-diacetic acid trisodium salt in the form of a crystal, comprising a crystalline modification referred to as crystal type III characterized by the below reflections when analyzed with X...  
WO/2019/007943A1
The present invention relates to a process for the preparation of a solid composition of an amino acid diacetic acid compound wherein the amino acid diacetic acid compound is methyl glycine-N,N-diacetic acid or a salt thereof, or glutami...  
WO/2019/002022A1
The present invention is directed towards a process for manufacturing a complexing agent, said process comprising the steps of (a) Providing a nitrile according to general formula (I a) or (I b) (formula I a, I b) With M being selected f...  
WO/2019/002685A1
The present invention relates to a process for in situ the preparation of mixtures of chelating agents by catalyzed reactions of diethanolamine derivatives with maleic acid and then with 2-halocarboxylic acid, to mixtures of chelating ag...  
WO/2019/002684A1
The present invention relates to a process for the in situ preparation of mixtures of chelating agents by catalyzed reactions of diethanolamine with maleic acid and then with 2-halocarboxylic acid, mixtures obtainable using said process ...  
WO/2018/231747A3
Methods of synthesizing fluoroquinolones such as ciprofloxacin are provided. The methods utilize affordable materials, reduce the number of synthesis steps and provide high yields.  
WO/2018/226841A1
Zwitterionic monomers, camitine-derived zwitterionic polymers, carnitine ester cationic monomers, carnitine ester cationic polymers, conjugate compositions including a carnitine-derived zwitterionic polymer, and related compositions' and...  
WO/2018/223836A1
The present invention relates to a novel crystal form of a compound (I), a method for preparing same, and an application. Crystal form CS3, crystal form CS2, crystal form CS5, and crystal form CS8 of the compound (I) provided by the pres...  
WO/2018/226340A1
A method for preparing diphenol compounds includes adding a hydroxyphenyl carboxylic acid, a tyrosine ethyl ester, hydroxybenzotriazole hydrate and a solvent and stirring to produce a first solution, EDCI HCI is added to the first soluti...  
WO/2018/225871A1
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, R1 represents a hydrogen atom or a hydroxymethyl group; n1 represents 1 or 2; A1 and A2 may be the same ...  
WO/2018/212162A1
The purpose of the present invention is to provide a method for easily producing a diaminobenzene compound and a benzimidazole compound at low cost. The present invention provides a method for producing a diaminobenzene compound or N-pro...  
WO/2018/206540A1
Materials of the invention are suitable for use in coating compositions, inks, paints, varnishes, adhesives, for the making of gel coats, composites, molding compositions or 3D articles. Materials of the invention are in particular suita...  
WO/2018/207693A1
A 1–amino cyclopropane carboxylic acid nonhydrate can be produced as a result of: using a tertiary amine to treat a 1–amino cyclopropane carboxylic acid hydrochloride in the presence of a C3–C4 alcohol and water; maintaining the re...  
WO/2018/207694A1
A 1–amino cyclopropane carboxylic acid nonhydrate can be produced as a result of: using a tertiary amine to treat a 1–amino cyclopropane carboxylic acid hydrochloride in the presence of a C3–C4 alcohol and water; maintaining the re...  
WO/2018/208754A1
This invention relates to compositions and methods for treating or ameliorating symptoms of a neuropsychiatric disease in a subject in need thereof comprising: (a) a therapeutically effective amount of propofol; and (b) a therapeutically...  
WO/2018/208677A1
Embodiments of the present disclosure are related to improved processes for making L-ornithine phenylacetate without using any silver salts or forming any L-ornithine intermediate salts, such as a benzoate salt. The present processes may...  
WO/2018/204434A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases in agriculturally useful row crops.  
WO/2018/204438A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases on turfgrasses.  
WO/2018/204435A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S)-l,l-bis(4-fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L- alaninate, and at least one fungicide selected from the group con...  
WO/2018/204437A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S)-1,1-bis(4-fluorophenyl)propan-2-y1 (3-acetoxy-4-methoxypicolinoy1)-L-alaninate, and at least one fungicide selected from the group cons...  
WO/2018/204869A1
The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.  
WO/2018/204431A1
The present disclosure relates to the use of the compound of Formula I, (S)-1,1-bis(4- fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L-alaninate, as a seed treatment to prevent or control plant diseases.  
WO/2018/204436A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S) -1,1-bis (4-fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L-alaninate, and at least one fungicide selected from the group co...  
WO/2018/204433A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases in agriculturally useful orchard, vineyard and plantation crops.  
WO/2018/204432A1
The present disclosure is related to the field of agrochemicals, including compound (I) and its use to control fungal diseases in agriculturally useful vegetable crops.  
WO/2018/197475A1
The present invention provides processes for preparing a compound of formula (I) and pharmaceutically acceptable salts thereof, comprising deprotecting a compound of formula (II), wherein each R3 independently represents a tertiary alkyl...  
WO/2018/177383A1
The present application relates to extracting, from a traditional Chinese medicine, a plurality of compounds capable of prompting nucleic acid delivery or synthetic compounds, and promoting nucleic acid such as sRNA to absorb and enter a...  
WO/2018/176150A1
Novel methods for isolating fish roe/egg extracts, notably a coagulum and a sediment extract, enriched in phospholipids and omega-3 fatty acids are described. Novel compositions comprising omega-3 polyunsaturated fatty acids and micronut...  
WO/2018/174826A1
This invention relates to a method for producing an alkenyl 1 -aminocyclopropane-1 -carboxylic acid of Formula I wherein R1 is a protecting group, n is an integer between 1 and 10, and A and B are chiral centres such that when A is S, B ...  
WO/2018/170322A1
Provided herein are novel solid forms of each of four compounds: (1) heptadecan-9-yl 8-((2-hydroxyethyl)amino)octanoate ("Compound 1"), (2) heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoat e ("Compound 2"),(3)...  

Matches 1 - 50 out of 14,131